AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (276.7 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Perspective | Open Access

Rethinking nasopharyngeal carcinoma management: toward a low-toxicity, highly effective regimen with favorable tolerability and quality of life

Yingni Zhang1,2,*, Chunxian Ou1,3,*, Cheng Xu1 ( )
Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China
Sun Yat-sen University School of Medicine, Sun Yat-sen University, Shenzhen 518000, China
Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou 510060, China

*These authors contributed equally to this work.

Show Author Information

References

【1】
【1】
 
 
Cancer Biology & Medicine
Pages 1353-1360

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Zhang Y, Ou C, Xu C. Rethinking nasopharyngeal carcinoma management: toward a low-toxicity, highly effective regimen with favorable tolerability and quality of life. Cancer Biology & Medicine, 2026, 23(10): 1353-1360. https://doi.org/10.20892/j.issn.2095-3941.2026.0316

6

Views

1

Downloads

0

Crossref

0

Web of Science

0

Scopus

Received: 15 April 2026
Accepted: 08 July 2026
Published: 08 August 2026
©2026 The Authors.

Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)